Autor: Firma Tentamus Group

CONIDIA CONIPHY joins Tentamus

Tentamus Group is proud to welcome CONIDIA CONIPHY as its newest member of the global network of laboratories. CONIDIA CONIPHY offers market leading microbiological expertise. Sébastien Vacher, CEO of CONIDIA CONIPHY is excited: “It was our goal to find a strategic and international partner that follows a similar entrepreneurial spirit as we do. Joining the […]

Read More

Non-targeted analysis – Beginning of a new era?

Is my olive oil really from Italy? Or does my honey contain any sugar syrup? Or my paprika any colorants? In the past, so-called targeted analyses were used to answer these questions. Targeted means, that only one or few parameters of known identity, i.e. a known substance like a sudan dye, was analyzed. The drawback […]

Read More

A new company is joining the Tentamus Group in Italy!

Tentamus Group is proud to welcome ISEMED Srl to its international network of laboratories and service providers. ISEMED, based in Imola (BO), Italy, provides consulting services for medical devices, in vitro diagnostic medical devices, pharmaceuticals, and cosmetics on the European and international market. ISEMED experienced and trusted partner to its customers, supporting its customers’ technical, […]

Read More

KEYBIO successfully audited following its move in La Ciotat

For more than 30 years, KEYBIO has always made sure to keep its values centered on expertise, transparency of methods, information and customer care at the forefront. KEYBIO, a laboratory entirely dedicated to microbiology, operates in the Healthcare (Medical Devices and Pharmaceuticals), Cosmetics and Biocides sectors. At the end of 2021, the laboratory moved to […]

Read More

KEYBIO a été audité avec succès après son déménagement à La Ciotat

Depuis sa création il y a 30 ans, KEYBIO a toujours veillé à respecter ses valeurs centrées sur l’expertise, la transparence des méthodes, l’information et l’écoute client. Laboratoire entièrement voué à la microbiologie, KEYBIO intervient dans les secteurs de la Santé (Dispositifs Médicaux et Produits Pharmaceutiques), de la Cosmétique et des Biocides. Fin 2021, le […]

Read More

Malolactic & Biogenic Amines: Organoleptic alterations of wine

Malolactic Fermentation (MLF) is the result of the metabolic activity of lactic bacteria present in wine which perform an enzymatic decarboxylation of malic acid into lactic acid and carbon dioxide. The lactic bacteria involved belong to four genera: Oenococcus, Leuconostoc, Lactobacillus and Pediococcus. The products of MLF include lactic acid and subsequently molecules which describe […]

Read More

Tentamus Group strengthens DACH-region with new finance manager

The Tentamus Group welcomes Mr. Stefan Lüdtge as new Finance Manager for the DACH-region. Mr. Lüdtge started on June 01, 2022 and will be primarily responsible for finance and the strategic development of the regions Germany, Austria and Switzerland in the future. Stefan Lüdtge was born in Ludwigsfelde in 1987 and studied business administration. Lutz […]

Read More

Tentamus Group verstärkt DACH-Region mit neuem Finance Manager

Die Tentamus Group begrüßt Herrn Stefan Lüdtge als neuen Finance Manager für die DACH-Region. Herr Lüdtge startete am 01. Juni 2022 und wird zukünftig vornehmlich den Bereich Finanzen und die strategische Weiterentwicklung der Regionen Deutschland, Österreich und Schweiz verantworten. Stefan Lüdtge wurde 1987 in Ludwigsfelde geboren und ist studierter Betriebswirt. Lutz Lehmann, Country Manager DACH-Region […]

Read More

Minerva Scientific introduces matrine and oxymatrine testing of honey

There have been four EU RASSF alerts concerning detectable levels of the pesticides oxymatrine and matrine in Chinese honey within the past 12 months, with most of these alerts relating specifically to Chinese Acacia honey. There was also a product recall of retail Acacia honey containing ‘high’ levels of oxymatrine in France in August last […]

Read More

Erfolgreiche Inspektion unserer drei Tentamus Pharma & Med Deutschland Standorte

Die Tentamus Pharma & Med Deutschland GmbH freut sich, Ihnen mitteilen zu können, dass die im September 2021 gegründete Tentamus Pharma & Med Deutschland GmbH (TPMD) an allen drei Laborstandorten von den lokalen GMP-Behörden erfolgreich inspiziert worden ist. Damit ist ein nahtloser Übergang der GMP Genehmigung sichergestellt. Die TPMD ging aus der Fusion der drei […]

Read More